NCT03021096

Brief Summary

This study aims to identify the timeline of pain following total shoulder replacement with the goal of developing data for a subsequent randomized trial. The investigators believe that with using HSS's current protocol, many patients have postoperative pain that is no worse than their preoperative pain. Previous HSS anesthesia protocols for total shoulder arthroplasty patients have not formally followed patients past their hospital discharge, and the investigators believe that some patients do experience moderate to severe subacute postoperative pain. Therefore, this study's primary outcome is to look at the numeric pain scores at 14 days after surgery. Future studies will look at measures of preventing bruising and subsequent pain after shoulder replacement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 13, 2017

Completed
14 days until next milestone

Study Start

First participant enrolled

January 27, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2018

Completed
7 years until next milestone

Results Posted

Study results publicly available

March 4, 2025

Completed
Last Updated

March 4, 2025

Status Verified

January 1, 2025

Enrollment Period

11 months

First QC Date

January 3, 2017

Results QC Date

April 19, 2022

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Numeric Rating Scale Pain Scores at Post-operative Day 14

    Quantifying patients' pain at a sub-acute time point after surgery at rest and with movement. The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

    14 days after surgery for each patient

Secondary Outcomes (9)

  • Numeric Rating Scale (NRS) Pain With Movement and at Rest.

    Days 1 day (POD0), 3 days(POD3), 7 days(POD7) and 3 months(POD90) after surgery

  • Opioid Consumption (in Past 24 Hours)

    Days 1 day, 3 days, 7 days after surgery

  • Opioid Related Symptom Distress Scale

    Day 1 after surgery

  • Range of Motion

    Day 14 after surgery and 3 months after surgery

  • Severity of Bruising

    Day 14 after surgery

  • +4 more secondary outcomes

Interventions

SurveysOTHER

The study is just using validated surveys to assess pain and mood states after surgery

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing TSA for Osteoarthritis, Reverse, Anatomic procedures

You may qualify if:

  • All patients eligible for the standardized anesthetic for TSA
  • Patients who are capable to provide informed consent and answer questions in English (Study involves questionnaires validated in English)
  • Age 18-80

You may not qualify if:

  • Incapable to provide informed consent
  • Contraindications for regional anesthesia (anticoagulation, infection at injection site)
  • Patients undergoing TSA for Trauma or Rheumatoid Arthritis
  • Conversion of hemiarthroplasty to TSA
  • Planned use of tranexamic acid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery

New York, New York, 10021, United States

Location

Related Publications (2)

  • Goon AK, Dines DM, Craig EV, Gordon MA, Goytizolo EA, Lin Y, Lin E, YaDeau JT. A clinical pathway for total shoulder arthroplasty-a pilot study. HSS J. 2014 Jul;10(2):100-6. doi: 10.1007/s11420-014-9381-0. Epub 2014 Mar 8.

    PMID: 25050091BACKGROUND
  • YaDeau JT, Gordon MA, Goytizolo EA, Lin Y, Fields KG, Goon AK, Holck G, Miu TW, Gulotta LV, Dines DM, Craig EV. Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study. Pain Med. 2016 May;17(5):940-60. doi: 10.1093/pm/pnv010. Epub 2015 Dec 14.

    PMID: 26814246BACKGROUND

MeSH Terms

Conditions

ContusionsPain, Postoperative

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Wounds, NonpenetratingWounds and InjuriesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Results Point of Contact

Title
Dr Jacques Yadeau
Organization
Hospital for Special Surgery, Anesthesiology

Study Officials

  • Jacques YaDeau, MD, PhD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2017

First Posted

January 13, 2017

Study Start

January 27, 2017

Primary Completion

December 18, 2017

Study Completion

March 22, 2018

Last Updated

March 4, 2025

Results First Posted

March 4, 2025

Record last verified: 2025-01

Locations